Browsing Tag
acute ischemic stroke
2 posts
Lumosa Therapeutics reports Phase 2 functional gains for LT3001 in disabling acute ischemic stroke
Lumosa Therapeutics’ LT3001 Phase 2 stroke data show functional gains beyond standard windows. Find out what this means for Phase 3 and investors.
BRILINTA FDA approval: A major step in reducing stroke risks in acute ischemic stroke and high-risk TIA patients
AstraZeneca has secured U.S. Food and Drug Administration (FDA) approval for BRILINTA (ticagrelor), expanding its use to reduce…